|
US5641628A
(en)
|
1989-11-13 |
1997-06-24 |
Children's Medical Center Corporation |
Non-invasive method for isolation and detection of fetal DNA
|
|
WO1994002156A1
(en)
|
1992-07-16 |
1994-02-03 |
The Board Of Trustees Of Leland Stanford Junior University |
Methods for using dendritic cells to activate t cells
|
|
US6821778B1
(en)
|
1993-12-01 |
2004-11-23 |
The Board Of Trustees Of Leland Stanford Junior University |
Methods for using dendritic cells to activate gamma/delta-T cell receptor-positive T cells
|
|
WO1995024217A1
(en)
*
|
1994-03-08 |
1995-09-14 |
Dana-Farber Cancer Institute |
Methods for modulating t cell unresponsiveness
|
|
AUPM446594A0
(en)
|
1994-03-16 |
1994-04-14 |
Csl Limited |
Cytotoxic t-cell epitopes identified within epstein-barr virus
|
|
PT772624E
(pt)
|
1994-04-06 |
2001-03-30 |
Immunex Corp |
Interleucina-15
|
|
PT804210E
(pt)
|
1994-05-16 |
2003-04-30 |
Roche Diagnostics Gmbh |
Processo de imunomodelacao por transferencia adoptiva de linfocitos t citotoxicos especificos de um antigenio
|
|
US6300090B1
(en)
|
1994-07-29 |
2001-10-09 |
The Rockefeller University |
Methods of use of viral vectors to deliver antigen to dendritic cells
|
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
|
PT747481E
(pt)
|
1995-06-06 |
2002-05-31 |
Organon Teknika Bv |
Peptidos do virus de epstein-barr e anticorpos contra estes peptidos
|
|
FR2745185B1
(fr)
|
1996-02-28 |
1998-05-15 |
Sanofi Sa |
Utilisation de l'il-7 dans le traitement des maladies auto-immunes, en particulier le diabete mellitus insulinodependant
|
|
US6699477B2
(en)
|
1996-05-24 |
2004-03-02 |
The Council Of The Queensland Institute Of Medical Research |
EBV CTL epitopes
|
|
US5962318A
(en)
|
1996-11-15 |
1999-10-05 |
St. Jude Children's Research Hospital |
Cytotoxic T lymphocyte-mediated immunotherapy
|
|
WO1998033888A1
(en)
|
1997-01-31 |
1998-08-06 |
Epimmune, Inc. |
Peptides and peptide-loaded antigen presenting cells for the activation of ctl
|
|
US6528307B1
(en)
|
1997-04-25 |
2003-03-04 |
The Wistar Institute Of Anatomy And Biology |
Cytolytic T-cell clones against colorectal carcinoma
|
|
US7951383B2
(en)
*
|
1997-05-23 |
2011-05-31 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated parainfluenza virus (PIV) vaccines
|
|
AUPO784197A0
(en)
|
1997-07-10 |
1997-08-07 |
Csl Limited |
Treatment of nasopharyngeal carcinoma
|
|
ATE428769T1
(de)
|
1997-10-27 |
2009-05-15 |
Univ Rockefeller |
Methode und zusammensetzung zur herstellung von reifen dendritischen zellen
|
|
US20020155108A1
(en)
|
1998-05-04 |
2002-10-24 |
Biocrystal, Ltd. |
Method for ex vivo loading of antigen presenting cells with antigen, and a vaccine comprising the loaded cells
|
|
WO2000050569A1
(en)
*
|
1999-02-24 |
2000-08-31 |
The Wistar Institute Of Anatomy And Biology |
Method of modifying cytotoxic cells and uses thereof
|
|
US6828147B1
(en)
|
1999-02-24 |
2004-12-07 |
The Wistar Institute Of Anatomy And Biology |
Method of modifying cytotoxic cells and uses thereof
|
|
US7005131B1
(en)
|
1999-08-13 |
2006-02-28 |
The Rockefeller University |
Protective antigen of Epstein Barr Virus
|
|
US20150037297A1
(en)
|
1999-08-30 |
2015-02-05 |
David S Terman |
Sickled Erythrocytes and Progenitors Target Cytotoxics to Tumors
|
|
AU2425801A
(en)
|
1999-11-24 |
2001-06-04 |
Ernest G. Hope |
Anti-angiogenic cellular agent for cancer therapy
|
|
DE10009341A1
(de)
|
2000-02-22 |
2001-09-06 |
Florian Kern |
Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
|
|
US20020155127A1
(en)
|
2000-06-02 |
2002-10-24 |
Danher Wang |
Genetic vaccine against human immunodeficiency virus
|
|
DK2336187T3
(en)
|
2000-06-19 |
2016-08-22 |
Beth Israel Deaconess Medical Ct Inc |
Compositions and Methods of monoclonal and polyclonal antibodies which are specific for T-cell subpopulations
|
|
AU2001288863A1
(en)
|
2000-09-15 |
2002-03-26 |
Ortho-Mcneil Pharmaceutical, Inc. |
Compositions and methods for inducing specific cytolytic t cell responses
|
|
EP1229043A1
(en)
|
2001-01-30 |
2002-08-07 |
Cyto-Barr B.V. |
Peptides derived from Epstein Barr virus (EBV) proteins LMP1, LMP2 and BARF1 antibody reagents reactive therewith
|
|
GB0107628D0
(en)
|
2001-03-27 |
2001-05-16 |
Avidex Ltd |
Substances
|
|
US20040022761A1
(en)
|
2001-05-11 |
2004-02-05 |
Banchereau Jacques F |
Compositions and methods for producing antigen-presenting cells
|
|
ATE438710T1
(de)
|
2001-05-15 |
2009-08-15 |
Ortho Mcneil Janssen Pharm |
Ex-vivo-priming zur erzeugung cd40-ligand spezifischer zytotoxischer t-lymphozyten zur behandlung von autoimmun- und allergischen erkrankungen
|
|
UA75429C2
(en)
|
2001-09-28 |
2006-04-17 |
|
Mowing blade
|
|
EP1444330A1
(en)
|
2001-11-07 |
2004-08-11 |
Kirin Beer Kabushiki Kaisha |
Expansion of t cells in vitro and expanded t cell populations
|
|
US20030148982A1
(en)
|
2001-11-13 |
2003-08-07 |
Brenner Malcolm K. |
Bi-spcific chimeric T cells
|
|
RU2313365C2
(ru)
|
2001-11-29 |
2007-12-27 |
Дандрит Байотек А/С |
Фармацевтическая композиция для индукции иммунной реакции у человека
|
|
US20040096457A1
(en)
|
2001-12-11 |
2004-05-20 |
Huber Brigitte T |
Treatment and prevention of ebv infection and ebv-associated disorders
|
|
US7745140B2
(en)
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
WO2003057171A2
(en)
|
2002-01-03 |
2003-07-17 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of t-cells using an engineered multivalent signaling platform
|
|
WO2004041849A1
(en)
|
2002-11-07 |
2004-05-21 |
The Council Of The Queensland Institute Of Medical Research |
Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor
|
|
AU2002953238A0
(en)
|
2002-12-09 |
2003-01-02 |
The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland |
In vitro immunization
|
|
IL158140A0
(en)
|
2003-09-25 |
2004-03-28 |
Hadasit Med Res Service |
Multiepitope polypeptides for cancer immunotherapy
|
|
CN101120083B
(zh)
|
2003-10-08 |
2013-03-27 |
威尔森沃尔夫制造公司 |
利用透气性材料进行细胞培养的方法及装置
|
|
US20050221481A1
(en)
|
2004-03-30 |
2005-10-06 |
Istituto Superiore Di Sanita' |
Amplification of T cells from human cord blood in serum-deprived culture stimulated with stem cell factor, interleukin-7 and interleukin-2
|
|
US7785806B2
(en)
|
2004-04-28 |
2010-08-31 |
Vaxdesign Corporation |
Method for determining the immunogenicity of an antigen
|
|
AU2005250408B2
(en)
|
2004-05-27 |
2010-09-23 |
The Trustees Of The University Of Pennsylvania |
Novel artificial antigen presenting cells and uses therefor
|
|
US7785875B2
(en)
|
2004-07-03 |
2010-08-31 |
Mogam Biotechnology Research Institute |
Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same
|
|
US20060045883A1
(en)
|
2004-08-26 |
2006-03-02 |
Jeffrey Molldrem |
Anti-cancer vaccines
|
|
JP4731867B2
(ja)
|
2004-10-01 |
2011-07-27 |
国立大学法人三重大学 |
Ｃｄ８陽性の細胞傷害性ｔリンパ球の誘導方法
|
|
WO2006099448A2
(en)
|
2005-03-14 |
2006-09-21 |
University Of Iowa Research Foundation |
Accelerated cd8+ t-cell memory after dendritic cell vaccination
|
|
EP1712615A1
(en)
|
2005-04-15 |
2006-10-18 |
Txcell |
In vitro production of a cell population using feeder cells
|
|
ES2334936T3
(es)
*
|
2005-04-20 |
2010-03-17 |
F. Hoffmann-La Roche Ag |
Metodo de identificacion de epitopos relacionados con la inmunogenicidad en biofarmacos.
|
|
WO2006124412A2
(en)
|
2005-05-11 |
2006-11-23 |
The Trustees Of The University Of Pennsylvania |
Methods for the rapid expansion of antigen specific t-cells
|
|
US20070003531A1
(en)
|
2005-06-30 |
2007-01-04 |
University Of Connecticut |
Methods for improving immunotherapy by enhancing survival of antigen-specific cytotoxic T lymphocytes
|
|
US20100035282A1
(en)
|
2005-08-03 |
2010-02-11 |
Maria Chiara Bonini |
Use of common gamma chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes
|
|
JP4824389B2
(ja)
|
2005-10-28 |
2011-11-30 |
株式会社医学生物学研究所 |
エプスタイン−バールウイルス感染細胞を特異的に攻撃する細胞傷害性ｔ細胞エピトープペプチド及びその用途
|
|
JP5492418B2
(ja)
|
2005-11-18 |
2014-05-14 |
ザ オハイオ ステート ユニバーシティー リサーチ ファウンデーション |
ウイルス関連疾患を予防するためのウイルス遺伝子産物およびワクチン接種の方法
|
|
GB0604170D0
(en)
|
2006-03-02 |
2006-04-12 |
Antitope Ltd |
T cell assays
|
|
PL1989544T3
(pl)
|
2006-03-02 |
2012-01-31 |
Antitope Ltd |
Testy na komórkach T
|
|
US20070243549A1
(en)
|
2006-04-12 |
2007-10-18 |
Biocept, Inc. |
Enrichment of circulating fetal dna
|
|
WO2008025992A2
(en)
|
2006-09-01 |
2008-03-06 |
Cambridge Enterprise Limited |
Methods of expanding non-effector cd8 t-cell populations
|
|
EP2091961A4
(en)
|
2006-11-22 |
2009-12-09 |
Univ Arkansas |
IMMUNOTHERAPY AGAINST CANCER WITH MULTIPPITOP-PEPTIDE-LOADED DENDRITIC CELLS
|
|
AU2007332869B2
(en)
|
2006-12-07 |
2012-10-11 |
Wilson Wolf Manufacturing, LLC |
Highly efficient gas permeable devices and methods for culturing cells
|
|
DK2117571T3
(en)
|
2006-12-08 |
2017-05-08 |
Monopar Therapeutics Inc |
Urokinase-type plasminogen activator receptor epitope
|
|
DE102006060824B4
(de)
*
|
2006-12-21 |
2011-06-01 |
Johannes-Gutenberg-Universität Mainz |
Nachweis von individuellen T-Zell-Reaktionsmustern gegen Tumor-assoziierte Antigene (TAA) in Tumorpatienten als Basis für die individuelle therapeutische Vakzinierung von Patienten
|
|
WO2008148170A1
(en)
*
|
2007-06-08 |
2008-12-11 |
The University Of Queensland |
Human metapneumovirus immunogenic peptides, compositions, and methods of use
|
|
CA2700618A1
(en)
|
2007-09-27 |
2009-04-02 |
The Board Of Trustees Of The University Of Arkansas |
Inhibition of dendritic cell-driven regulatory t cell activation and potentiation of tumor antigen-specific t cell responses by interleukin-15 and map kinase inhibitor
|
|
EP2060583A1
(en)
|
2007-10-23 |
2009-05-20 |
Ganymed Pharmaceuticals AG |
Identification of tumor-associated markers for diagnosis and therapy
|
|
US20100254958A1
(en)
|
2007-10-24 |
2010-10-07 |
Anne Letsch |
Antigen-Specific T-Cell Preparations from Bone Marrow
|
|
JP2011502484A
(ja)
|
2007-11-01 |
2011-01-27 |
メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ |
Ｈｌａ−ｄｒ結合性ペプチドおよびそれらの使用
|
|
EP2065462A1
(en)
|
2007-11-27 |
2009-06-03 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens
|
|
EP2321407A4
(en)
|
2008-09-11 |
2012-07-18 |
Univ Florida |
SYSTEM AND METHOD FOR THE PRODUCTION OF T-CELLS
|
|
CN101824400B
(zh)
|
2009-03-05 |
2012-08-08 |
中国科学院微生物研究所 |
一种放大增殖抗原特异性t细胞的方法
|
|
EP3101122B1
(en)
|
2009-08-24 |
2023-06-14 |
Baylor College of Medicine |
Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses
|
|
JP5833443B2
(ja)
|
2009-08-29 |
2015-12-16 |
株式会社バイオメッドコア |
抗原特異的ｔ細胞誘導能測定法
|
|
GB0917090D0
(en)
|
2009-09-29 |
2009-11-11 |
Ucl Biomedica Plc |
T-cell receptor
|
|
US8956860B2
(en)
|
2009-12-08 |
2015-02-17 |
Juan F. Vera |
Methods of cell culture for adoptive cell therapy
|
|
US8809050B2
(en)
|
2009-12-08 |
2014-08-19 |
Wilson Wolf Manufacturing |
Methods of cell culture for adoptive cell therapy
|
|
US20130115617A1
(en)
|
2009-12-08 |
2013-05-09 |
John R. Wilson |
Methods of cell culture for adoptive cell therapy
|
|
BR112012029066A2
(pt)
*
|
2010-05-14 |
2020-09-01 |
The General Hospital Corporation |
composições e processos de identificação de neoantígenos específicos de tumor.
|
|
US9114100B2
(en)
|
2010-05-17 |
2015-08-25 |
Duke University |
Methods of treatment using ex vivo expansion of cord blood T cells
|
|
EP2600890A1
(en)
|
2010-08-04 |
2013-06-12 |
Instituto Europeo di Oncologia S.r.l. |
Method of antigen loading for immunotherapy
|
|
US8741642B2
(en)
|
2010-10-22 |
2014-06-03 |
Virginia Commonwealth University |
Methods for producing autologous immune cells resistant to myeloid-derived suppressor cells effects
|
|
EP2453243A1
(en)
|
2010-11-11 |
2012-05-16 |
Cosmo S.p.A. |
Method for the diagnosis and/or follow up of the evolution of a tumor
|
|
US20130045491A1
(en)
|
2011-07-19 |
2013-02-21 |
Derya Unutmaz |
Methods for activating t cells
|
|
AU2012305931B2
(en)
|
2011-09-08 |
2017-09-07 |
Yeda Research And Development Co. Ltd |
Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
|
|
GB201121308D0
(en)
|
2011-12-12 |
2012-01-25 |
Cell Medica Ltd |
Process
|
|
CN104769104A
(zh)
|
2011-12-12 |
2015-07-08 |
细胞药物有限公司 |
扩大t细胞的方法
|
|
PT2812431T
(pt)
|
2012-02-09 |
2019-10-18 |
Baylor College Medicine |
Pepmixes para gerar ctls multivirais com larga especifidade
|
|
US20130217122A1
(en)
|
2012-02-21 |
2013-08-22 |
The Trustees Of The University Of Pennsylvania |
Expansion of Interferon-Gamma-Producing T-Cells Using Glypican-3 Peptide Library
|
|
HK1207667A1
(en)
|
2012-05-08 |
2016-02-05 |
Western University Of Health Sciences |
Standardized ex vivo platforms for the antigen-specific expansion of cd4+ t cell populations
|
|
US10357515B2
(en)
|
2013-11-22 |
2019-07-23 |
Cellectis |
Method for generating batches of allogeneic T-cells with averaged potency
|
|
US20160341718A1
(en)
|
2014-01-21 |
2016-11-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for testing t cell priming efficacy in a subject
|
|
WO2016073595A1
(en)
|
2014-11-05 |
2016-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
T cells and dendritic cells for polyomavirus therapy
|
|
MY189857A
(en)
|
2014-11-05 |
2022-03-14 |
Memorial Sloan Kettering Cancer Center |
Methods of selecting t cell line and donor thereof for adoptive cellular therapy
|
|
IL294055A
(en)
|
2015-03-20 |
2022-08-01 |
Childrens Nat Medical Ct |
Generating virus or other antigen-specific t cells from a naive t cell population
|
|
HK1254397A1
(zh)
|
2015-06-26 |
2019-07-19 |
纪念斯隆-凯特林癌症中心 |
通过t细胞疗法治疗cmv视网膜炎的方法
|
|
JP6999941B2
(ja)
|
2015-09-18 |
2022-02-10 |
ベイラー カレッジ オブ メディスン |
病原体からの免疫原性抗原同定および臨床的有効性との相関
|
|
MX2018013959A
(es)
|
2016-05-25 |
2019-08-22 |
Council Queensland Inst Medical Res |
Metodos para tratar enfermedad autoinmune usando celulas t alogenicas.
|
|
AU2017326173B2
(en)
|
2016-09-16 |
2022-08-18 |
Baylor College Of Medicine |
Platform for activation and expansion of virus-specific T-cells
|
|
US20200172864A1
(en)
|
2016-09-26 |
2020-06-04 |
Tessa Therapeutics Ltd. |
T Cell Expansion Method
|
|
WO2018232467A1
(en)
|
2017-06-22 |
2018-12-27 |
The Westmead Institute for Medical Research |
Adoptive t cell therapy 2
|
|
JP2020533688A
(ja)
|
2017-09-06 |
2020-11-19 |
ナント ホールディングス アイピー，エルエルシー |
Ｈｌａ組織照合およびそのための方法
|
|
GB201808651D0
(en)
|
2018-05-25 |
2018-07-11 |
Rolls Royce Plc |
Rotor blade arrangement
|
|
IL286629B2
(en)
|
2019-03-25 |
2024-10-01 |
Baylor College Medicine |
Multi-respiratory virus antigen-specific t cells and methods of making and using the same therapeutically
|
|
TWI777160B
(zh)
|
2019-05-08 |
2022-09-11 |
美商百歐恩泰美國公司 |
T細胞製備組合物及方法
|
|
AU2020297019A1
(en)
|
2019-06-20 |
2022-02-17 |
Janssen Sciences Ireland Unlimited Company |
Carbohydrate nanocarrier delivery of hepatitis B virus (HBV) vaccines
|
|
US20220257654A1
(en)
|
2019-07-23 |
2022-08-18 |
Baylor College Of Medicine |
Antigen-specific t cell banks and methods of making and using the same therapeutically
|
|
MX2022001322A
(es)
|
2019-07-29 |
2022-05-24 |
Baylor College Medicine |
Bancos de células t específicas de antígeno y métodos para fabricar y usar los mismos terapéuticamente.
|
|
AU2020333654A1
(en)
|
2019-08-16 |
2022-03-17 |
Baylor College Of Medicine |
Third party virus-specific T cell compositions, and methods of making and using the same in anti-viral prophylaxis
|
|
US20230028788A1
(en)
|
2019-12-23 |
2023-01-26 |
Baylor College Of Medicine |
T cell performance assay as a prognostic factor for clinical outcome
|
|
WO2021189084A1
(en)
|
2020-03-20 |
2021-09-23 |
Baylor College Of Medicine |
Sars-cov2-specific t cell compositions and their use in treating and preventing coronavirus and other respiratory virus infections
|
|
EP3974029A1
(en)
|
2020-09-25 |
2022-03-30 |
Universidad Autónoma de Madrid |
Memory t cells as adoptive cell therapy for viral infections
|